Nektar Therapeutics (NKTR) vs OPKO Health, Inc. (OPK)

A side-by-side comparison of Nektar Therapeutics and OPKO Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NKTR vs OPK

growth of $100 · dividends reinvested · last 10y
NKTR -82.3% (-15.9%/yr)OPK -83.4% (-16.4%/yr)NKTR compounded faster over this window
0200400600Start $10020182020202220242026$18$17
NKTR OPK

NKTR vs OPK: by the numbers

  • •NKTR is the larger company ($1.14B vs $1.09B market cap).
  • •Both run net losses; OPK's is the smaller (-12.40% vs -287.84% net margin).
  • •Both shrank revenue over the past five years; NKTR's decline was smaller (-12.34% vs -21.00% CAGR).

Metrics side by side

Valuation

MetricNKTROPK
P/S ratio20.961.86
P/B ratio1.270.92

Profitability

MetricNKTROPK
Gross margin99.36%21.10%
Operating margin-240.38%-36.08%
Net margin-287.84%-12.40%
ROE-17.40%-6.16%
ROIC-12.53%-8.86%

Growth (annualized)

MetricNKTROPK
Revenue CAGR (5Y)-12.34%-21.00%
Total return CAGR (5Y)-30.33%-15.39%

Frequently asked

Which has grown faster, NKTR or OPK?
Neither grew: over the past five years both shrank revenue, with NKTR's decline the smaller — NKTR at a -12.34% CAGR versus OPK at -21.00%.
How have NKTR and OPK total returns compared?
Over the past 10 years, NKTR delivered -16.49% and OPK delivered -17.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.